In early work (1980's), he discovered mobile genetic elements in halophilic Archaea,[4][5] while a graduate student with H. Gobind Khorana (Nobel laureate) and Uttam L. RajBhandary at MIT. He also showed that transcriptional promoters in Archaea[6] were different from those in common Bacteria, which contributed to the acceptance of the three Domain view of evolution proposed by Carl Woese.
In the 1990s, he organized and led the team that deciphered the first genome sequence and genetic code for a halophilic microbe, Halobacterium sp. NRC-1.[7][8][9] This work showed that its proteins are highly acidic, providing an understanding of how proteins may function in high salinity and low water activity conditions.[10][11][12] The genome sequence helped to further establish the validity of the Archaea[13] through the finding of similarities to higher eukaryotic organisms and differences from Bacteria.
Later in the 2000s, his work also suggested that certain genes are acquired through horizontal gene transfers, such as the genes for aerobic respiration. Post-genomic research in his laboratory established the core and signature proteins in halophilic Archaea,[14] and the function of many genes and genetic elements, including multiple replication origins,[15] general transcription factors,[16] and DNA repair systems.[17][18]
Astrobiology
DasSarma's recent research (2010's) on an Antarctic halophilic microorganism, Halorubrum lacusprofundi, resulted in further refinement in understanding of protein function in a combination of high salinity and cold conditions.[19] Such studies may explain how life could adapt to new environments, including extraterrestrial environments.[20]
DasSarma proposed that retinal pigments originally discovered in halophilic Archaea may have predated chlorophyll pigments in the early earth, named the "Purple Earth" hypothesis.[2][21] This proposal provides a potential new biosignature for remote detection of life.
Biotechnology
DasSarma's laboratory has been instrumental in the study of buoyant gas vesicle nanoparticles (GVNPs) in Halobacterium sp. NRC-1, and developed an expression system to bioengineer GVNPs for biotechnology applications.[22] These nanoparticles may represent a valuable platform for antigen delivery, vaccine development, and other biomedical and environmental applications[23][24]
^DasSarma, S., J.A. Coker, and P. DasSarma. 2010. Archaea - Overview. In Encyclopedia of Microbiology, 3rd edition, Academic Press, M. Schaechter (ed.), p. 118-139.